Voyager Therapeutics (VYGR)
(Delayed Data from NSDQ)
$7.65 USD
+0.04 (0.53%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $7.65 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -0.44 |
EPS Last Quarter | 1.25 |
Last EPS Surprise | 311.86% |
ABR | 1.20 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.64 |
Next Year | -1.49 |
EPS (TTM) | 3.09 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 10.33M | 10.50M | 46.41M | 85.81M |
# of Estimates | 3 | 2 | 4 | 3 |
High Estimate | 16.00M | 16.00M | 90.14M | 154.92M |
Low Estimate | 5.00M | 5.00M | 5.00M | 25.00M |
Year ago Sales | 150.48M | 4.85M | 250.01M | 46.41M |
Year over Year Growth Est. | -93.13% | 116.49% | -81.44% | 84.89% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.44 | -0.48 | -1.64 | -1.49 |
# of Estimates | 4 | 3 | 5 | 5 |
Most Recent Consensus | -0.31 | -0.32 | -1.28 | -1.29 |
High Estimate | -0.31 | -0.32 | -0.61 | 0.15 |
Low Estimate | -0.50 | -0.60 | -2.33 | -2.50 |
Year ago EPS | 2.94 | -0.51 | 2.97 | -1.64 |
Year over Year Growth Est. | -114.97% | 5.88% | -155.22% | 9.15% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 1 | 2 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 1 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.44 | -0.48 | -1.64 | -1.49 |
7 Days Ago | -0.44 | -0.48 | -1.64 | -1.49 |
30 Days Ago | -0.44 | -0.48 | -1.64 | -1.49 |
60 Days Ago | -0.63 | -0.65 | -1.91 | -1.31 |
90 Days Ago | -0.63 | -0.65 | -1.91 | -1.31 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.44 | -0.48 | -1.64 | -1.49 |
Zacks Consensus Estimate | -0.44 | -0.48 | -1.64 | -1.49 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.25 | -0.59 | -0.51 | 2.94 | NA |
Estimate | -0.59 | -0.58 | -0.59 | 0.15 | NA |
Difference | 1.84 | -0.01 | 0.08 | 2.79 | 1.18 |
Surprise | 311.86% | -1.72% | 13.56% | 1,860.00% | 545.93% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more